ArticleACS chemical biology2024

A High-Throughput Screening Platform Identifies FDA-Approved Drugs That Inhibit SREBP Pathway Activation.

Chiaki T Ishida et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.